SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-17-020803
Filing Date
2017-04-03
Accepted
2017-04-03 06:20:51
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a17-10291_1s3.htm S-3 357514
2 EX-5.1 a17-10291_1ex5d1.htm EX-5.1 33317
3 EX-12.1 a17-10291_1ex12d1.htm EX-12.1 29595
4 EX-23.1 a17-10291_1ex23d1.htm EX-23.1 2762
5 GRAPHIC g102911bei001.jpg GRAPHIC 3635
6 GRAPHIC g102911kei001.gif GRAPHIC 2197
  Complete submission text file 0001104659-17-020803.txt   432500
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217102 | Film No.: 17732226
SIC: 2834 Pharmaceutical Preparations